Medications for Epilepsies Myoclonic

37 results

  • Clonazepam (clonazepam)

    (Clonazepam)
    TYA Pharmaceuticals
    Usage: Clonazepam is indicated for the treatment of Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures in patients unresponsive to succinimides. It is also prescribed for panic disorder, characterized by unexpected panic attacks and associated behavioral changes. Long-term efficacy requires periodic reevaluation.

  • Clonazepam (clonazepam)

    (CLONAZEPAM)
    Alembic Pharmaceuticals Inc.
    Usage: Clonazepam orally disintegrating tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Its long-term efficacy has not been systematically studied, prompting periodic reevaluation for ongoing use.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Aphena Pharma Solutions - Tennessee, LLC
    Usage: Clonazepam is indicated for treating seizure disorders, including Lennox-Gastaut syndrome and absence seizures that resist other treatments. It is also used to manage panic disorder, characterized by unexpected panic attacks and behavior changes related to the attacks. Long-term efficacy has not been systematically studied.

  • Clonazepam (clonazepam)

    (Clonazepam)
    RPK Pharmaceuticals, Inc.
    Usage: Clonazepam tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome, akinetic, myoclonic, and absence seizures unresponsive to succinimides. They are also effective for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks and related behavioral changes. Long-term effectiveness has not been systematically studied.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Aurobindo Pharma Limited
    Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term effectiveness has not been extensively studied.

  • Clonazepam (clonazepam)

    (CLONAZEPAM)
    DIRECT RX
    Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome and certain types of absence seizures. It is also approved for panic disorder, characterized by recurrent panic attacks. Long-term efficacy beyond nine weeks has not been systematically studied. Regular re-evaluation by a physician is advised.

  • Clonazepam (clonazepam)

    (Clonazepam)
    REMEDYREPACK INC.
    Usage: Clonazepam tablets are indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Their efficacy in long-term use beyond nine weeks has not been systematically studied. Regular reassessment is recommended.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Teva Pharmaceuticals USA, Inc.
    Usage: Clonazepam is indicated for the treatment of seizure disorders such as Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as for panic disorder, with or without agoraphobia. Its efficacy for long-term use beyond nine weeks has not been systematically studied.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Chartwell RX, LLC
    Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as absence seizures unresponsive to succinimides. It is also used to treat panic disorder, with or without agoraphobia, characterized by recurrent panic attacks.

  • Clonazepam (clonazepam)

    (Clonazepam)
    Coupler LLC
    Usage: Clonazepam is indicated for treating seizure disorders, including Lennox-Gastaut syndrome, akinetic, myoclonic, and absence seizures that resist succinimides. It is also used for panic disorder, characterized by unexpected panic attacks and significant behavioral changes, though long-term efficacy is not well-studied. Regular reevaluation is advised.